CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15
Mar 06, 2018 13:00 pm UTC| Business
NEWARK, Calif., March 06, 2018 -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...
Mar 06, 2018 13:00 pm UTC| Business
DULUTH, Ga., March 06, 2018 -- Innovative Architects has been awarded a 2018 Top Workplaces honor by The Atlanta Journal-Constitution for the fifth consecutive year. This distinction is based solely on employee feedback...
Provant Health Boosts Flu Immunity for Employees Across the U.S.
Mar 06, 2018 13:00 pm UTC| Business
OLATHE, Kan., March 06, 2018 -- Provant Health announced today that its convenient influenza vaccination (“flu shot”) options for employers have resulted in nearly 100,000 workers across the U.S. being immunized against...
MyoKardia to Present at the Cowen and Company 38th Annual Health Care Conference
Mar 06, 2018 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 06, 2018 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Albireo to Present at 38th Annual Cowen and Company Health Care Conference
Mar 06, 2018 13:00 pm UTC| Business
BOSTON, March 06, 2018 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive...
Global Food Safety Testing Market Volume, Forecast & Analysis 2018-2024
Mar 06, 2018 12:57 pm UTC| Business
Dublin, March 06, 2018 -- The "Food Safety Testing Market, Volume, Forecast Global Analysis, by Contaminants, by Technology, by Regions Companies" report has been added to ResearchAndMarkets.com's offering....
Mar 06, 2018 12:56 pm UTC| Business
DENVER, March 06, 2018 -- Centennial Resource Development, Inc. (“Centennial” or the “Company”) (NASDAQ:CDEV) today announced the pricing of an underwritten public offering of an aggregate of 25,000,000 shares of Class...